Search research articles
Contact Us
Filters
Showing results (1-10 of 110) with videos related to
Page
of 11
Sort By:
Infectious Diseases and Therapy
|
March 17, 2021
The Place of Meropenem-Vaborbactam in the Management of Carbapenem-Resistant Gram-Negative Infections
Teena Chopra
Expert Review of Anti-Infective Therapy
|
February 9, 2023
A profile of the live biotherapeutic product RBX2660 and its role in preventing recurrent <i>Clostridioides difficile</i> infection
Teena Chopra
Therapeutic Advances in Gastroenterology
|
January 7, 2022
Fecal microbiota transplantation for recurrent <i>Clostridioides difficile</i>, safety, and pitfalls
Avnish Sandhu, Teena Chopra
Infection Control and Hospital Epidemiology
|
April 22, 2020
Detroit under siege, the enemy within: The impact of the COVID-19 collision
Teena Chopra, Jack Sobel
Infectious Disease Clinics of North America
|
November 9, 2021
Prevention of Infection due to Clostridium (Clostridioides) difficile
Amar Krishna, Teena Chopra
Expert Opinion on Pharmacotherapy
|
January 28, 2010
Treatment strategies for infective endocarditis
Teena Chopra, Glenn W Kaatz
Biologics : Targets & Therapy
|
February 7, 2018
Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent <i>Clostridium difficile</i> infection
Bhagyashri D Navalkele, Teena Chopra
Frontiers in Microbiomes
|
March 19, 2026
Clinical application of live biotherapeutic products in infectious diseases
Bhagyashri D Navalkele, Teena Chopra
Infectious Disease Clinics of North America
|
May 6, 2026
Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician
Lea Monday, Amar Krishna, Teena Chopra
Infectious Disease Clinics of North America
|
February 15, 2011
Infection prevention in alternative health care settings
Elaine Flanagan, Teena Chopra, Lona Mody
Page
of 11
Search research articles
Search
Showing results (1-10 of 110) with videos related to
Sort By:
Page
of 11
Infectious Diseases and Therapy
|
March 17, 2021
The Place of Meropenem-Vaborbactam in the Management of Carbapenem-Resistant Gram-Negative Infections
Teena Chopra
Expert Review of Anti-Infective Therapy
|
February 9, 2023
A profile of the live biotherapeutic product RBX2660 and its role in preventing recurrent <i>Clostridioides difficile</i> infection
Teena Chopra
Therapeutic Advances in Gastroenterology
|
January 7, 2022
Fecal microbiota transplantation for recurrent <i>Clostridioides difficile</i>, safety, and pitfalls
Avnish Sandhu, Teena Chopra
Infection Control and Hospital Epidemiology
|
April 22, 2020
Detroit under siege, the enemy within: The impact of the COVID-19 collision
Teena Chopra, Jack Sobel
Infectious Disease Clinics of North America
|
November 9, 2021
Prevention of Infection due to Clostridium (Clostridioides) difficile
Amar Krishna, Teena Chopra
Expert Opinion on Pharmacotherapy
|
January 28, 2010
Treatment strategies for infective endocarditis
Teena Chopra, Glenn W Kaatz
Biologics : Targets & Therapy
|
February 7, 2018
Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent <i>Clostridium difficile</i> infection
Bhagyashri D Navalkele, Teena Chopra
Frontiers in Microbiomes
|
March 19, 2026
Clinical application of live biotherapeutic products in infectious diseases
Bhagyashri D Navalkele, Teena Chopra
Infectious Disease Clinics of North America
|
May 6, 2026
Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician
Lea Monday, Amar Krishna, Teena Chopra
Infectious Disease Clinics of North America
|
February 15, 2011
Infection prevention in alternative health care settings
Elaine Flanagan, Teena Chopra, Lona Mody
Page
of 11